1. Home
  2. STXS vs STIM Comparison

STXS vs STIM Comparison

Compare STXS & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • STIM
  • Stock Information
  • Founded
  • STXS 1990
  • STIM 2003
  • Country
  • STXS United States
  • STIM United States
  • Employees
  • STXS N/A
  • STIM N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • STIM Medical/Dental Instruments
  • Sector
  • STXS Health Care
  • STIM Health Care
  • Exchange
  • STXS Nasdaq
  • STIM Nasdaq
  • Market Cap
  • STXS 275.9M
  • STIM 224.8M
  • IPO Year
  • STXS 2004
  • STIM 2018
  • Fundamental
  • Price
  • STXS $2.79
  • STIM $2.80
  • Analyst Decision
  • STXS
  • STIM Strong Buy
  • Analyst Count
  • STXS 0
  • STIM 2
  • Target Price
  • STXS N/A
  • STIM $7.00
  • AVG Volume (30 Days)
  • STXS 505.0K
  • STIM 1.3M
  • Earning Date
  • STXS 11-11-2025
  • STIM 11-04-2025
  • Dividend Yield
  • STXS N/A
  • STIM N/A
  • EPS Growth
  • STXS N/A
  • STIM N/A
  • EPS
  • STXS N/A
  • STIM N/A
  • Revenue
  • STXS $31,806,000.00
  • STIM $129,873,000.00
  • Revenue This Year
  • STXS $30.98
  • STIM $105.70
  • Revenue Next Year
  • STXS $49.86
  • STIM $11.77
  • P/E Ratio
  • STXS N/A
  • STIM N/A
  • Revenue Growth
  • STXS 33.94
  • STIM 78.61
  • 52 Week Low
  • STXS $1.54
  • STIM $0.52
  • 52 Week High
  • STXS $3.59
  • STIM $5.92
  • Technical
  • Relative Strength Index (RSI)
  • STXS 39.75
  • STIM 44.74
  • Support Level
  • STXS $2.68
  • STIM $2.38
  • Resistance Level
  • STXS $3.15
  • STIM $3.09
  • Average True Range (ATR)
  • STXS 0.12
  • STIM 0.25
  • MACD
  • STXS -0.04
  • STIM -0.01
  • Stochastic Oscillator
  • STXS 21.04
  • STIM 43.53

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Share on Social Networks: